FDA Drug Recalls

Recalls / Class II

Class IID-0548-2022

Product

APAP 325 mg (Acetaminophen 325 mg, Pamabrom 25 mg tablet) Bulk Container, ULTRAtab Laboratories, Inc., Highland, NY NDC 62959-700-00

Affected lot / code info
Product Codes: M700LA Bulk Lots: 18K037, 18L093, 18M006, 19A121, 19G044, 19G045, 19G046

Why it was recalled

CGMP Deviations

Recalling firm

Firm
ULTRAtab Laboratories, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
50 Toc Dr, N/A, Highland, New York 12528-1506

Distribution

Quantity
6,380,282 tablets
Distribution pattern
Bulk product was distributed to 3 distributors who may have distributed finished product.

Timeline

Recall initiated
2022-01-26
FDA classified
2022-02-09
Posted by FDA
2022-02-16
Terminated
2025-01-07
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0548-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.